Formula Pharmaceuticals, Inc. is a privately-held
biopharmaceutical company developing a proprietary, next generation
Chimeric Antigen Receptor (CAR) immunotherapy platform. Formula’s
technology platform offers important opportunities for improvements to
existing CAR approaches, with the objective to significantly increase
patient access, clinical benefit potential, and cost-effectiveness of
Health & Fitness jobs
in your inbox.